Patent details
EP2409690 Title: Improved stability of progestogen formulations
Basic Information
- Publication number:
- EP2409690
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP111757936
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Improved stability of progestogen formulations
- French Title of Invention:
- Stabilité améliorée de formulations de progestogène
- German Title of Invention:
- Verbesserte Stabilität von Progestogenformulierungen
- SPC Number:
Dates
- Filing date:
- 21/09/2004
- Grant date:
- 09/11/2022
- EP Publication Date:
- 25/01/2012
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 09/11/2022
- EP B1 Publication Date:
- 09/11/2022
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 21/09/2023
- Expiration date:
- 21/09/2024
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 02/11/2022
- Name:
- Novo Nordisk Health Care AG
- Address:
- -, The Circle 32/388058 Zürich-Flughafen, Switzerland (CH)
Inventor
- Name:
- FRIIS, Vibeke
- Address:
- Denmark (DK)
Priority
1
- Priority Number:
- 200301408
- Priority Date:
- 29/09/2003
- Priority Country:
- Denmark (DK)
2
- Priority Number:
- 509962 P
- Priority Date:
- 09/10/2003
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 9/20; A61K 9/28; A61K 31/565; A61K 31/567;
Publication
European Patent Bulletin
- Issue number:
- 202245
- Publication date:
- 09/11/2022
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|